News from shire plc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Oct 24, 2014, 07:00 ET

Shire's Clear and Focused Strategy Delivers Record Quarterly Revenues. Non GAAP Diluted Earnings per ADS up 60%

 - Increases Non GAAP diluted earnings per ADS growth guidance to the high thirty percent range for the full year (2014).  Shire (LSE:...

Oct 20, 2014, 17:22 ET

Shire plc: AbbVie Terminates Offer for Shire

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION...

Oct 20, 2014, 02:00 ET

Interim Chief Financial Officer James Bowling to Step Down

Shire plc (LSE: SHP, NASDAQ: SHPG) announces that James Bowling, Interim Chief Financial Officer (CFO), has notified the Board of Directors of his...

Oct 16, 2014, 04:31 ET

Shire plc: Statement re: AbbVie's Withdrawal of Recommendation

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION...

Oct 15, 2014, 14:32 ET

Shire plc: Statement re: Waiver of Notice of AbbVie's Board Meeting

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION...

Oct 15, 2014, 02:13 ET

Shire plc: Statement re: AbbVie's Intention to Reconsider Recommendation

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION...

Oct 09, 2014, 04:30 ET

Shire Provides Regulatory Update on SHP 465, Investigational Compound for ADHD in Adults

Shire plc (LSE: SHP, NASDAQ: SHPG) today announced that it has received further guidance from the U.S. Food and Drug Administration (FDA) on the...

Sep 24, 2014, 16:06 ET

Shire Reaches Final Agreement with U.S. Government

Shire plc (LSE: SHP, NASDAQ: SHPG), today announced that it has reached a final agreement with the U.S. Attorney's Offices for the Eastern...

Sep 15, 2014, 08:00 ET

Shire Announces FDA Acceptance for Filing with Priority Review of Supplemental New Drug Application (sNDA) for Vyvanse® (lisdexamfetamine dimesylate) Capsules (CII) for Adults with Binge Eating Disorder

Shire plc (LSE: SHP, NASDAQ: SHPG), the global specialty biopharmaceutical company, announced today that the US Food and Drug Administration (FDA)...

Jul 23, 2014, 07:00 ET

Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen

Shire plc (LSE: SHP, NASDAQ: SHPG), the global specialty biopharmaceutical company, and ArmaGen, a US privately held biotechnology company, today...

Jul 18, 2014, 06:14 ET

Shire Delivers Record Quarterly Revenues and Non GAAP Diluted Earnings per ADS up 42%

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION...

Jul 17, 2014, 13:30 ET

Shire Reports Top-Line Results From Two Head-to-Head Studies Comparing Vyvanse® (lisdexamfetamine dimesylate), CII, With Concerta® (methylphenidate HCl), CII, in Adolescents with ADHD

Shire plc (LSE: SHP, NASDAQ: SHPG) today announced top-line results from two Phase 4 efficacy and safety studies of Vyvanse®...

Jul 14, 2014, 02:34 ET

Shire plc: Update re: AbbVie Proposal

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION...

Jul 11, 2014, 14:00 ET

Shire plc - Statement re: Media Speculation

Not for release, publication or distribution (in whole or in part) in, into or from any jurisdiction where to do so would constitute a violation...

Jul 08, 2014, 09:44 ET

Shire plc - Statement re: AbbVie Announcement

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION...

Jun 30, 2014, 02:00 ET

Shire Receives US$248 Million Cash Refund From the Canadian Revenue Authorities, Expects a Further US$162 Million in Late 2014

Shire plc ("Shire" or the "Company") (LSE: SHP, NASDAQ: SHPG) announces that its Canadian subsidiary(1) has received assessments from the Canadian...

Jun 25, 2014, 11:47 ET

Shire Comments on AbbVie's Unchanged Proposal

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION...

Jun 25, 2014, 02:44 ET

Vyvanse® Patents Found to Be Infringed and Valid by U.S. District Court

Shire plc (LSE: SHP, NASDAQ: SHPG) announces that Judge Stanley R. Chesler of the U.S. District Court for the District of New Jersey granted...

Jun 23, 2014, 07:33 ET

Shire plc: the Path to US$10 Billion in Product Sales by 2020

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION...

Jun 23, 2014, 02:00 ET

Shire to Host Investor Call

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION...